Key Takeaways
- ASTS shares surged approximately 11% Thursday following confirmation that three additional BlueBird satellites will deploy in August via SpaceX’s Falcon 9 rocket.
- The updated deployment timeline establishes a rhythm of one launch every two months, potentially delivering up to 18 satellites annually.
- The company is currently building 24 satellites (BlueBirds 14–37), with orbital deployment targeted for completion by late 2027.
- Institutional ownership stands at approximately 61% of outstanding shares, while insiders have divested more than $280 million in stock over the past three months.
- Wall Street consensus leans toward “Reduce” with an average price target of $85.09; shares opened Monday at $71.57.
AST SpaceMobile (ASTS) shares advanced approximately 11% during Thursday’s session, closing at $71.58, without any immediate news release that day — though the rally followed closely after the company unveiled an aggressive satellite deployment schedule that captured investor attention.
Earlier during the week, AST provided confirmation that BlueBird satellites 11, 12, and 13 are scheduled for an August deployment utilizing SpaceX’s Falcon 9 launch vehicle. This announcement follows the June 17 successful orbital insertion of BlueBirds 8, 9, and 10.
The consecutive deployment windows position AST’s launch frequency at approximately one mission every two months, establishing a potential yearly deployment rate reaching 18 satellites.
AST is actively manufacturing 24 satellites — specifically BlueBirds 14 through 37. Maintaining the current deployment velocity, the organization anticipates completing orbital placement by year-end 2027, coinciding with the planned commencement of beta operations for its direct-to-cell (DTC) connectivity network.
An international dimension is also emerging. Statements associated with a Vodafone-supported deployment referenced Spain as a prospective early commercial territory, with a tentative 2027 launch window — strengthening the international revenue narrative.
Wall Street Perspective and Price Forecasts
Despite investor excitement reflected in the share price, analyst sentiment remains reserved to pessimistic. The consensus analyst recommendation for ASTS currently registers as “Reduce,” accompanied by a mean price forecast of $85.09.
Deutsche Bank recently downgraded its stance from buy to hold while reducing its price objective from $117 to $106. B. Riley shifted to “neutral” with an $85 projection. Roth MKM represents one of the more optimistic voices, maintaining a “buy” recommendation and a $108 price objective.
Among ten tracked analysts, just one maintains a buy recommendation. Six advocate holding. Three recommend selling.
The equity’s 50-day moving average registers at $87.18, while its 200-day average sits at $89.23 — both substantially above present trading levels.
Significant Insider Divestment Activity
One element that warrants attention: company insiders have been actively reducing positions.
During the previous 90-day period, insiders liquidated over 3.1 million shares valued at approximately $280.6 million. Notable transactions include CFO Andrew Martin Johnson, who divested 45,809 shares at an average price of $93.81 on June 11, trimming his holdings by 8.34%.
Director Julio A. Torres similarly sold 15,000 shares at $76.34 during May, decreasing his position by roughly 26%.
Insider ownership currently represents 20.89% of outstanding shares, while institutional investors control 60.95%.
SG Americas Securities LLC expanded its ASTS position by 18.6% during Q1, acquiring 11,813 additional shares to reach a total holding of 75,157.
Regarding financial performance, AST’s Q1 results disappointed. The company reported an EPS of -$0.66, falling short of analyst expectations of -$0.23. Revenue registered at $14.73 million versus projected $39.01 million.
Analysts project full-year EPS of -$1.47. The stock’s 52-week trading range spans from $36.08 to $133.86.


